These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 3459701)

  • 1. [Kidney tolerance of imipenem and cilastatin].
    Hammer C; Grevemeyer B; Sido B; Krombach F; Mihatsch MJ; Mraz W
    Fortschr Med; 1986 May; 104(20):417-20. PubMed ID: 3459701
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephroprotective effect of imipenem/cilastatin in reducing cyclosporine toxicity.
    Sido B; Hammer C; Mraz W; Krombach F
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1755-8. PubMed ID: 3469804
    [No Abstract]   [Full Text] [Related]  

  • 3. [Outline of imipenem/cilastatin sodium].
    Jpn J Antibiot; 1986 May; 39(5):1432-5. PubMed ID: 3463789
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal tolerance of imipenem/cilastatin and other beta-lactam antibiotics in rats.
    Sack K; Herhahn J; Marre R; Schulz E
    Infection; 1985; 13 Suppl 1():S156-60. PubMed ID: 3863794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do imipenem and cilastatin interfere with the determination of serum creatinine?].
    Dauchy F
    Pathol Biol (Paris); 1988 May; 36(5):511-2. PubMed ID: 3043349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the degradation of imipenem within serum and a renal kidney fraction.
    Köller M; Brom J; Schönfeld W; Knöller J; König W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 May; 261(3):330-7. PubMed ID: 3090805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pneumonia with imipenem/cilastatin.
    Beasley CR; Humble MW; O'Donnell TV
    N Z Med J; 1985 Jun; 98(781):494-7. PubMed ID: 3859775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
    Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the mammalian beta-lactamase renal dipeptidase (dehydropeptidase-I) by (Z)-2-(acylamino)-3-substituted-propenoic acids.
    Graham DW; Ashton WT; Barash L; Brown JE; Brown RD; Canning LF; Chen A; Springer JP; Rogers EF
    J Med Chem; 1987 Jun; 30(6):1074-90. PubMed ID: 3495664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients.
    Engelhard D; Shalit I; Stutman HR; Greenwood R; Griffis J; Marks MI
    Pediatr Pharmacol (New York); 1986; 5(4):273-9. PubMed ID: 3461422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of multiple doses of imipenem/cilastatin.
    Drusano GL; Standiford HC; Bustamante CI; Rivera G; Forrest A; Leslie J; Tatem B; Delaportas D; Schimpff SC
    Clin Pharmacol Ther; 1985 May; 37(5):539-43. PubMed ID: 3886256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxic and peroxidative potential of meropenem and imipenem/cilastatin in rat and human renal cortical slices and microsomes.
    Yousif T; Pooyeh S; Hannemann J; Baumann J; Tauber R; Baumann K
    Int J Clin Pharmacol Ther; 1999 Oct; 37(10):475-86. PubMed ID: 10543314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of cyclosporin (CSA) nephrotoxicity by imipenem/cilastatin after kidney transplantation in rats.
    Hammer C; Thies JC; Mraz W; Mihatsch M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):931. PubMed ID: 2650296
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of neurotoxic side effects by coadministration of imipenem to cyclosporine therapy in a kidney transplant recipient--synergism of side effects or drug interaction?
    Zazgornik J; Schein W; Heimberger K; Shaheen FA; Stockenhuber F
    Clin Nephrol; 1986 Nov; 26(5):265-6. PubMed ID: 3467883
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy and tolerability of imipenem/cilastatin in infections at various sites].
    Grassi C; Baglioni A; Bonsignore G; Catena E; De Rose V; Grignani F; Lotti T; Orlandi O; Panichi G; Pavone Macaluso M
    G Ital Chemioter; 1986; 33(2-3):143-8. PubMed ID: 3479372
    [No Abstract]   [Full Text] [Related]  

  • 18. Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
    Bigley FP; Forsyth RJ; Henley MW
    Am J Hosp Pharm; 1986 Nov; 43(11):2803-9. PubMed ID: 3467590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem-cilastatin sodium.
    Stene R
    Iowa Med; 1986 Sep; 76(9):432-7. PubMed ID: 3771166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.